Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,166,178 papers from all fields of science
Search
Sign In
Create Free Account
Indium 111In-satumomab pendetide
Known as:
B72.3-GYK-DTPA
, B72.3-glycyl-tyrosyl N-diethylenetriaminepentacetic acid
, Indium In 111 Satumomab Pendetide
Expand
An radioimmunoconjugate of the murine monoclonal antibody, Satumomab (MoAb B72.3), conjugated to the linker-chelator, glycyl-tyrosyl-(N…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Narrower (2)
CYT 103
OncoScint
Broader (3)
Monoclonal Antibodies
Oligopeptides
Pentetic Acid
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
S. Lapi
,
Hilla Wahnishe
,
+7 authors
E. Jones
Journal of Nuclear Medicine
2009
Corpus ID: 26016506
Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic…
Expand
Review
2003
Review
2003
Indium-111-capromab pendetide radioimmunoscintigraphy and prognosis for durable biochemical response to salvage radiation therapy in men after failed prostatectomy.
C. Thomas
,
P. Bradshaw
,
+7 authors
R. Wahl
Journal of clinical oncology : official journal…
2003
Corpus ID: 22139453
PURPOSE We evaluated the prognostic significance of indium-111 (111In)-capromab pendetide imaging for patients with prostate…
Expand
Highly Cited
2002
Highly Cited
2002
Clinical utility of indium 111‐capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy
G. Raj
,
A. Partin
,
T. Polascik
Cancer
2002
Corpus ID: 30494468
Despite the ability of radical prostatectomy to eradicate prostate carcinoma, biochemical evidence of recurrent prostate…
Expand
Review
2001
Review
2001
Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer.
S. Rosenthal
,
M. Haseman
,
T. Polascik
Techniques in urology
2001
Corpus ID: 25512026
PURPOSE Capromab pendetide (ProstaScint) is an indium In 111 ((111)In)-labeled monoclonal antibody to prostate-specific membrane…
Expand
Highly Cited
1999
Highly Cited
1999
Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse…
M. Seltzer
,
Z. Barbaric
,
+5 authors
C. Hoh
The Journal of urology
1999
Corpus ID: 13257197
Highly Cited
1999
Highly Cited
1999
Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura.
H. Louwes
,
O. A. Zeinali Lathori
,
E. Vellenga
,
J. D. de Wolf
The American journal of medicine
1999
Corpus ID: 25866559
Highly Cited
1999
Highly Cited
1999
Comparison of clinical staging algorithms and 111Indium‐capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients
T. Polascik
,
M. Manyak
,
+4 authors
A. Partin
Cancer
1999
Corpus ID: 7036317
The pretherapy prediction of occult lymph node involvement and the avoidance of otherwise futile and potentially morbid…
Expand
Highly Cited
1998
Highly Cited
1998
Radioimmunoscintigraphy with In-111-labeled capromab pendetide predicts prostate cancer response to salvage radiotherapy after failed radical prostatectomy.
D. Kahn
,
R. Williams
,
M. Haseman
,
N. Reed
,
S. Miller
,
J. Gerstbrein
Journal of clinical oncology : official journal…
1998
Corpus ID: 46148370
PURPOSE We investigated the ability of In-111-capromab pendetide to separate patients who have failed radical prostatectomy into…
Expand
Highly Cited
1998
Highly Cited
1998
Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium‐111 capromab pendetide
G. Hinkle
,
J. Burgers
,
+7 authors
R. Badalament
Cancer
1998
Corpus ID: 40304301
Optimum therapy for prostate carcinoma patients requires accurate staging, but computed tomography (CT) and magnetic resonance…
Expand
Highly Cited
1992
Highly Cited
1992
Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
B. Collier
,
H. Abdel-Nabi
,
+7 authors
E. Mitchell
Radiology
1992
Corpus ID: 7635243
Immunoscintigraphy performed after intravenous administration of indium-111-labeled CYT-103, an immunoconjugate of monoclonal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE